Microbial interactions in otitis media
中耳炎中的微生物相互作用
基本信息
- 批准号:7790700
- 负责人:
- 金额:$ 31.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-04-01 至 2014-03-31
- 项目状态:已结题
- 来源:
- 关键词:AccountingAddressAffectAntibiotic ResistanceAntibiotic TherapyAntibioticsBacteriaChildhoodChinchilla (genus)ChronicClinicalCommunitiesDataDiagnosisDiseaseEnvironmentHaemophilus influenzaeImmune responseImmunityIn VitroIncidenceIndividualInfectionInflammatory ResponseKnowledgeLearningLiquid substanceMicrobial BiofilmsModelingMoraxella (Branhamella) catarrhalisOffice VisitsOperative Surgical ProceduresOrganismOtitis MediaOutcomePathogenesisPatientsPopulationPrevalencePublic HealthRecurrenceResistanceSamplingSeveritiesSeverity of illnessStreptococcus pneumoniaeTreatment FailureTubeTympanostomybaseclinical practiceclinically relevanteconomic impactimprovedin vivoinsightmicroorganism interactionmiddle earnovelnovel strategiespathogenpatient populationpreventpublic health relevanceresponse
项目摘要
DESCRIPTION (provided by applicant): This project aims to define how polymicrobial infection influences bacterial otitis media. Haemophilus influenzae (Hi), Streptococcus pneumoniae (Sp), and Moraxella catarrhalis (Mcat) are the predominant isolates from patients with OM, and a wealth of evidence indicates that OM often involves combinations of these organisms. We hypothesize that interactions between bacterial species can impact OM disease parameters that include bacterial persistence, resistance to clearance and antibiotic treatment, and the initiation, progression and severity of the host inflammatory response. In order to address this hypothesis we will complete the following Specific Aims: Specific Aim 1: To define interactions among bacterial pathogens causing OM. Specific Aim 2: To ask how different interspecies relationships affect experimental OM. Specific Aim 3: To evaluate impact of polymicrobial infection on antibiotic resistance. Specific Aim 4: To establish the incidence of coinfection in patients undergoing tympanostomy. Most of our current knowledge about bacterial pathogenesis is derived from infection studies using pure cultures that may not fully represent how infections occur in actual patients. This proposal presents an opportunity to learn how multiple pathogens inhabiting the same ecological niche influence one another in biofilm communities that are critical to persistent infections. PUBLIC HEALTH RELEVANCE: Otitis media is a major common and costly pediatric illness worldwide, accounting for billions of dollars per year in total economic impact. Otitis media infections are the leading reason for pediatric office visits, new antibiotic prescriptions, and surgical instillation of tympanic drain tubes to relieve chronic and recurrent otitis media is the most commonly performed surgical procedure in the U.S. Haemophilus influenzae, Streptococcus pneumoniae, and Moraxella catarrhalis have long been recognized as the most common bacterial causes of otitis media, and it is now clear that many of these infections involve simultaneous infection with more than one organism. The focus of this application is to understand how these bacterial species interact in the biofilm communities that are a major determinant of bacterial persistence in vivo. Understanding how bacteria form these biofilms will be an important step in learning to better diagnose, prevent, and/or treat chronic infections.
描述(由申请人提供):本项目旨在确定多种微生物感染如何影响细菌性中耳炎。流感嗜血杆菌(Hi)、肺炎链球菌(Sp)和卡他莫拉菌(Mcat)是OM患者的主要分离株,大量证据表明OM通常涉及这些微生物的组合。我们假设细菌种类之间的相互作用可以影响OM疾病参数,包括细菌持久性,对清除和抗生素治疗的抗性,以及宿主炎症反应的开始,进展和严重程度。为了解决这一假设,我们将完成以下具体目标:具体目标1:定义引起OM的细菌病原体之间的相互作用。具体目标2:问不同的种间关系如何影响实验OM。具体目标3:评价多种微生物感染对抗生素耐药性的影响。具体目标4:确定接受鼓膜造孔术患者合并感染的发生率。我们目前关于细菌发病机制的知识大多来自使用纯培养物的感染研究,这些研究可能不能完全代表感染在实际患者中的发生。这项建议提供了一个机会,了解多种病原体栖息在同一个生态位相互影响的生物膜社区是至关重要的持续感染。公共卫生关系:中耳炎是全球范围内常见且昂贵的儿科疾病,每年造成数十亿美元的总经济影响。中耳炎感染是儿科门诊、新抗生素处方和鼓室引流管手术滴注以缓解慢性和复发性中耳炎的主要原因,这是美国最常进行的外科手术。流感嗜血杆菌、肺炎链球菌和卡他莫拉菌长期以来被认为是中耳炎最常见的细菌原因,现在很清楚,这些感染中有许多涉及同时感染一种以上的微生物。本申请的重点是了解这些细菌物种如何在生物膜群落中相互作用,生物膜群落是体内细菌持久性的主要决定因素。了解细菌如何形成这些生物膜将是学习更好地诊断,预防和/或治疗慢性感染的重要一步。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
WILLIAM E SWORDS其他文献
WILLIAM E SWORDS的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('WILLIAM E SWORDS', 18)}}的其他基金
Dysbiotic Infections in Chronic Obstructive Pulmonary Disease
慢性阻塞性肺病的菌群失调感染
- 批准号:
9629952 - 财政年份:2018
- 资助金额:
$ 31.14万 - 项目类别:
UAB Predoctoral Training Program in Lung Diseases
UAB 肺部疾病博士前培训项目
- 批准号:
10204089 - 财政年份:2017
- 资助金额:
$ 31.14万 - 项目类别:
Quorum signal eavesdropping by Moraxella catarrhalis
卡他莫拉氏菌窃听群体信号
- 批准号:
8323714 - 财政年份:2012
- 资助金额:
$ 31.14万 - 项目类别:
Quorum signal eavesdropping by Moraxella catarrhalis
卡他莫拉氏菌窃听群体信号
- 批准号:
8604707 - 财政年份:2012
- 资助金额:
$ 31.14万 - 项目类别:
Quorum signal eavesdropping by Moraxella catarrhalis
卡他莫拉氏菌窃听群体信号
- 批准号:
8423001 - 财政年份:2012
- 资助金额:
$ 31.14万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 31.14万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 31.14万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 31.14万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 31.14万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 31.14万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 31.14万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 31.14万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 31.14万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 31.14万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 31.14万 - 项目类别:
Research Grant